Source:http://linkedlifedata.com/resource/pubmed/id/11241757
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
2001-3-12
|
| pubmed:abstractText |
The Tg.AC transgenic mouse carries the v-Ha-ras oncogene under the control of the zeta-globin promoter and is currently being used in a short-term carcinogenesis assay for safety testing of pharmaceuticals. A subset of hemizygous Tg.AC mice was found to be nonresponsive to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate, which characteristically induces skin papillomas in these mice with repeated dermal applications. We previously showed that responder and nonresponder hemizygous Tg.AC mice carry about 40 copies of transgene but that the nonresponders had lost a 2-kb BamHI fragment containing the zeta-globin promoter sequence. The present restriction enzyme and S1 nuclease digestion experiments strongly suggested that the 2-kb BamHI fragment resulted from the orientation of two transgenes in an inverted repeat formation. Two subsets of nonresponder Tg.AC mice were identified. Restriction enzyme and S1 nuclease digestion experiments suggested that one nonresponder genotype was produced by a large deletion of one or more near complete copies of transgene sequence and the other genotype was produced by a small deletion near the apex of the "head-to-head" juncture of the inverted repeat. Polymerase chain reaction amplification, cloning, and sequencing results confirmed the palindromic orientation of transgene in Tg.AC mice. Our results indicated that, despite the presence of multiple copies of transgene in a direct repeat orientation, loss of symmetry in the palindromic array of transgene sequence results in the loss of the responder phenotype in Tg.AC mice. Mol. Carcinog. 30:99-110, 2001. Published 2001 Wiley-Liss, Inc.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Feb
|
| pubmed:issn |
0899-1987
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
30
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
99-110
|
| pubmed:dateRevised |
2008-11-21
|
| pubmed:meshHeading |
pubmed-meshheading:11241757-Animals,
pubmed-meshheading:11241757-Base Sequence,
pubmed-meshheading:11241757-Blotting, Southern,
pubmed-meshheading:11241757-DNA,
pubmed-meshheading:11241757-Gene Deletion,
pubmed-meshheading:11241757-Genes, ras,
pubmed-meshheading:11241757-Globins,
pubmed-meshheading:11241757-Mice,
pubmed-meshheading:11241757-Mice, Transgenic,
pubmed-meshheading:11241757-Molecular Sequence Data,
pubmed-meshheading:11241757-Nucleic Acid Conformation,
pubmed-meshheading:11241757-Phenotype,
pubmed-meshheading:11241757-Polymerase Chain Reaction,
pubmed-meshheading:11241757-Repetitive Sequences, Nucleic Acid,
pubmed-meshheading:11241757-Sequence Homology, Nucleic Acid,
pubmed-meshheading:11241757-Single-Strand Specific DNA and RNA Endonucleases,
pubmed-meshheading:11241757-Transgenes
|
| pubmed:year |
2001
|
| pubmed:articleTitle |
Loss of palindromic symmetry in Tg.AC mice with a nonresponder phenotype.
|
| pubmed:affiliation |
Center for Drug Evaluation and Research, Food and Drug Administration, Laurel, Maryland 20708, USA.
|
| pubmed:publicationType |
Journal Article,
Comparative Study
|